NA
NPSP

Navellier & Associates’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Navellier & Associates’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-19,349
Closed -$639K – 375
2014
Q2 		$639K Sell
19,349
-334
-2% -$9.65K 0.03% 153
2014
Q1 		$589K Buy
+19,683
New +$678K 0.03% 148

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Navellier & Associates's NPSP Position: Q3 2014 in Review

Navellier & Associates sold out of NPS PHARMACEUTICALS INC (NPSP) in Q3 2014, closing a stake of 19,349 shares — an estimated $639K sold.

Navellier & Associates first reported a position in NPSP in Q1 2014 and held it in 2 quarters. The position peaked at $639K in Q2 2014. 200 funds tracked by Wall St. Rank hold NPSP as of Q3 2014.

  • Navellier & Associates reported no remaining NPS PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Navellier & Associates sold 19,349 NPS PHARMACEUTICALS INC shares in Q3 2014, an estimated $639K.
  • Navellier & Associates first reported a position in NPS PHARMACEUTICALS INC in Q1 2014 and held it in 2 quarters.
  • Navellier & Associates's NPS PHARMACEUTICALS INC position peaked at $639K in Q2 2014.
  • 200 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q3 2014.

Based on Navellier & Associates's 13F filing for Q3 2014, filed 7 Oct 2014.